286 related articles for article (PubMed ID: 7942148)
1. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.
Fisher JE; Caulfield MP; Sato M; Quartuccio HA; Gould RJ; Garsky VM; Rodan GA; Rosenblatt M
Endocrinology; 1993 Mar; 132(3):1411-3. PubMed ID: 8440195
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of the s-echistatin inhibition of bone resorption.
Sato M; Garsky V; Majeska RJ; Einhorn TA; Murray J; Tashjian AH; Gould RJ
J Bone Miner Res; 1994 Sep; 9(9):1441-9. PubMed ID: 7817829
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones.
Gronowicz GA; Derome ME
J Bone Miner Res; 1994 Feb; 9(2):193-201. PubMed ID: 8140932
[TBL] [Abstract][Full Text] [Related]
5. Echistatin is a potent inhibitor of bone resorption in culture.
Sato M; Sardana MK; Grasser WA; Garsky VM; Murray JM; Gould RJ
J Cell Biol; 1990 Oct; 111(4):1713-23. PubMed ID: 2211834
[TBL] [Abstract][Full Text] [Related]
6. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
[TBL] [Abstract][Full Text] [Related]
7. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
Dresner-Pollak R; Rosenblatt M
J Cell Biochem; 1994 Nov; 56(3):323-30. PubMed ID: 7876325
[TBL] [Abstract][Full Text] [Related]
8. Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix.
van der Pluijm G; Most W; van der Wee-Pals L; de Groot H; Papapoulos S; Löwik C
Endocrinology; 1991 Sep; 129(3):1596-604. PubMed ID: 1874190
[TBL] [Abstract][Full Text] [Related]
9. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
Horton MA; Taylor ML; Arnett TR; Helfrich MH
Exp Cell Res; 1991 Aug; 195(2):368-75. PubMed ID: 1712731
[TBL] [Abstract][Full Text] [Related]
10. Effects of kistrin on bone resorption in vitro and serum calcium in vivo.
King KL; D'Anza JJ; Bodary S; Pitti R; Siegel M; Lazarus RA; Dennis MS; Hammonds RG; Kukreja SC
J Bone Miner Res; 1994 Mar; 9(3):381-7. PubMed ID: 8191932
[TBL] [Abstract][Full Text] [Related]
11. Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts.
Shankar G; Davison I; Helfrich MH; Mason WT; Horton MA
J Cell Sci; 1993 May; 105 ( Pt 1)():61-8. PubMed ID: 7689577
[TBL] [Abstract][Full Text] [Related]
12. The effect of tissue type plasminogen activator (tPA) on osteoclastic resorption in embryonic mouse long bone explants: a possible role for the growth factor domain of tPA.
Hoekman K; Löwik CW; van de Ruit M; Bijvoet OL; Verheijen JH; Papapoulos SE
Bone Miner; 1992 Apr; 17(1):1-13. PubMed ID: 1533805
[TBL] [Abstract][Full Text] [Related]
13. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
14. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
15. Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.
Carron CP; Meyer DM; Engleman VW; Rico JG; Ruminski PG; Ornberg RL; Westlin WF; Nickols GA
J Endocrinol; 2000 Jun; 165(3):587-98. PubMed ID: 10828842
[TBL] [Abstract][Full Text] [Related]
16. Integrin function in osteoclasts.
Rodan SB; Rodan GA
J Endocrinol; 1997 Sep; 154 Suppl():S47-56. PubMed ID: 9379137
[TBL] [Abstract][Full Text] [Related]
17. Beta 1 integrins and osteoclast function: involvement in collagen recognition and bone resorption.
Helfrich MH; Nesbitt SA; Lakkakorpi PT; Barnes MJ; Bodary SC; Shankar G; Mason WT; Mendrick DL; Väänänen HK; Horton MA
Bone; 1996 Oct; 19(4):317-28. PubMed ID: 8894137
[TBL] [Abstract][Full Text] [Related]
18. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin.
Helfrich MH; Nesbitt SA; Dorey EL; Horton MA
J Bone Miner Res; 1992 Mar; 7(3):335-43. PubMed ID: 1585836
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actions.
Shankar G; Gadek TR; Burdick DJ; Davison I; Mason WT; Horton MA
Exp Cell Res; 1995 Aug; 219(2):364-71. PubMed ID: 7543851
[TBL] [Abstract][Full Text] [Related]
20. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
